TABLE 2

The clinical outcomes are shown in Table 2.  There were 8506 participants in the Estrogen + Progestin group, and 8102 participants in the placebo group.  The data in the table shows that the treatment increased and decreased certain health risks for the group of participants who were in the Estrogen + Progestin group.  For health risks that have a Hazard Ratio greater than one, it means that the chances of getting that health risk increased with the treatment.  For health risks that have a Hazard Ratio less than one, it means that the chances of getting that health risk decreased with the treatment.